Company intelligence / Profile preview

SARDI

Switzerland

Ownership: Private
Development stage: Other

Overview

SARDI is an active private design consulting company focused on strategic industrial design rather than a biotechnology, pharmaceutical, or healthcare therapeutics business. The company presents itself as a global B2B industrial design expert and highlights work spanning industrial products, science instruments, and medical device design. Its materials emphasize product definition, ergonomics, usability, and design support for manufacturers rather than drug discovery or clinical development. While SARDI appears to have some relevance to medical device design, it does not appear to be a life science or biotech company with a therapeutic pipeline.

Industry: Consulting

Beyond the preview

Go deeper on SARDI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SARDI.

Explore the full profile